Company Filing History:
Years Active: 2003
Title: Sirkka Kyostio: Innovator in Gene Therapy
Introduction
Sirkka Kyostio is a notable inventor based in Ashland, MA (US). He has made significant contributions to the field of gene therapy, particularly through his innovative work with AAV vectors. His research focuses on developing methods for generating high titer, contaminant-free recombinant AAV vectors, which are crucial for effective gene therapy applications.
Latest Patents
Sirkka Kyostio holds a patent for "AAV vectors for gene therapy." This invention encompasses methods for producing recombinant AAV vectors in large quantities, ensuring high yields and purity. The patent also includes novel packaging cell lines that eliminate the need for cotransfection of vector and helper plasmids. Additionally, it provides methods for delivering transgenes to cells and describes transgenic non-human mammals that express a human chromosome 19 AAV integration locus.
Career Highlights
Kyostio is associated with Genzyme Corporation, where he has been instrumental in advancing gene therapy technologies. His work has paved the way for new treatments that utilize AAV vectors, enhancing the potential for successful gene delivery in various medical applications.
Collaborations
Sirkka Kyostio has collaborated with notable colleagues, including Samuel C. Wadsworth and Karen Vincent. These partnerships have contributed to the development and refinement of his innovative approaches in gene therapy.
Conclusion
Sirkka Kyostio's contributions to gene therapy through his patent on AAV vectors highlight his role as a leading inventor in this critical field. His work continues to influence advancements in medical treatments and therapies.